Franklin Resources Inc Cara Therapeutics, Inc. Transaction History

Franklin Resources Inc

  • $334 Billion
  • Q3 2024

A detailed history of Franklin Resources Inc transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 11,329 shares of CARA stock, worth $58,570. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,329
Previous 11,329 -0.0%
Holding current value
$58,570
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$1.67 - $3.33 $25,003 - $49,856
-14,972 Reduced 56.93%
11,329 $19,000
Q2 2023

Aug 11, 2023
BUY
$2.83 - $4.94 $32,046 - $55,940
11,324 Added 75.61%
26,301 $74,000
Q1 2023

May 12, 2023
SELL
$4.89 - $12.27 $1,594 - $4,000
-326 Reduced 2.13%
14,977 $73,000
Q4 2022

Feb 10, 2023
BUY
$8.88 - $12.77 $133 - $191
15 Added 0.1%
15,303 $164,000
Q3 2022

Nov 14, 2022
BUY
$8.24 - $12.56 $1,038 - $1,582
126 Added 0.83%
15,288 $143,000
Q2 2022

Aug 11, 2022
SELL
$7.45 - $13.84 $47,143 - $87,579
-6,328 Reduced 29.45%
15,162 $139,000
Q1 2022

May 13, 2022
BUY
$9.94 - $12.65 $213,610 - $271,848
21,490 New
21,490 $261,000
Q2 2020

Aug 13, 2020
SELL
$12.39 - $17.33 $6.97 Million - $9.75 Million
-562,800 Closed
0 $0
Q4 2019

Feb 12, 2020
SELL
$16.11 - $25.98 $190,098 - $306,564
-11,800 Reduced 2.05%
562,800 $9.07 Million
Q3 2019

Nov 14, 2019
BUY
$18.28 - $26.91 $2.27 Million - $3.34 Million
124,100 Added 27.55%
574,600 $10.5 Million
Q4 2017

Feb 14, 2018
BUY
$11.86 - $14.08 $189,760 - $225,280
16,000 Added 3.68%
450,500 $5.51 Million
Q3 2017

Nov 13, 2017
BUY
$12.6 - $16.34 $5.47 Million - $7.1 Million
434,500
434,500 $5.95 Million

Others Institutions Holding CARA

# of Institutions
74
Shares Held
12.8M
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $278M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email